GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redwood Scientific Technologies Inc (OTCPK:RSCI) » Definitions » EV-to-EBITDA

Redwood Scientific Technologies (Redwood Scientific Technologies) EV-to-EBITDA : (As of Jun. 04, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Redwood Scientific Technologies EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Redwood Scientific Technologies's enterprise value is $204.18 Mil. Redwood Scientific Technologies does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2022. Therefore, GuruFocus does not calculate Redwood Scientific Technologies's EV-to-EBITDA at this moment.

The historical rank and industry rank for Redwood Scientific Technologies's EV-to-EBITDA or its related term are showing as below:

RSCI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2346.05   Med: 0   Max: 0
Current: -1417.9
RSCI's EV-to-EBITDA is ranked worse than
100% of 711 companies
in the Drug Manufacturers industry
Industry Median: 14.26 vs RSCI: -1417.90

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-04), Redwood Scientific Technologies's stock price is $1.00. Redwood Scientific Technologies does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022. Therefore, GuruFocus does not calculate Redwood Scientific Technologies's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Redwood Scientific Technologies EV-to-EBITDA Historical Data

The historical data trend for Redwood Scientific Technologies's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Redwood Scientific Technologies EV-to-EBITDA Chart

Redwood Scientific Technologies Annual Data
Trend Dec20 Dec21 Dec22
EV-to-EBITDA
-181.20 - -7.41

Redwood Scientific Technologies Semi-Annual Data
Dec20 Dec21 Dec22
EV-to-EBITDA - - -7.41

Competitive Comparison of Redwood Scientific Technologies's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Redwood Scientific Technologies's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redwood Scientific Technologies's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redwood Scientific Technologies's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Redwood Scientific Technologies's EV-to-EBITDA falls into.


Redwood Scientific Technologies EV-to-EBITDA Calculation

Redwood Scientific Technologies's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=204.177/
=

Redwood Scientific Technologies  (OTCPK:RSCI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Redwood Scientific Technologies's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.00/
=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Redwood Scientific Technologies EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Redwood Scientific Technologies's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Redwood Scientific Technologies (Redwood Scientific Technologies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redwood Scientific Technologies Inc (OTCPK:RSCI) » Definitions » EV-to-EBITDA
Comparable Companies
HSTI BOM:512101 BOM:524322 BOM:524661 BOM:531686 TSXV:CIP.H BOM:524516 XCNQ:WRW BKIT BOM:531521 BOM:531015 XCNQ:DYME BOM:524606 BOM:526075 XCNQ:MJRX BOM:531762 YBAO XCNQ:RLSC BOM:533157 BOM:539680
Traded in Other Exchanges
N/A
Address
810 North Mountain Avenue, Suite 100, Upland, CA, USA, 91786
Website
https://www.redwoodsci.co
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets FDA-registered consumer homeopathic drugs and supplements. It utilized patent-pending sublingual strip delivery technology. It offers a product called TBX-FREE which is an oral strip that helps smokers safely and effectively eliminate the craving to smoke.